partner, Paul Hastings LLP
Peter Lindsay is a partner at Paul Hastings LLP with an FDA Regulatory and Enforcement practice focused on advising clients regarding a range of FDA regulatory, compliance, and enforcement issues, including those related to manufacturing (cGMPs/QSR) and other post-approval requirements. He has conducted significant internal reviews for life science companies addressing promotional activities, supplier management and supply chain risks, manufacturing activities, and safety reporting.
Latest from Peter Lindsay
Empatica Launch Next-Gen FDA-Cleared Epilepsy WatchMar 1, 2024|2 Min Read
Safeguard Medical Devices: A Complete Approach to Device Lifecycle SecurityApr 4, 2024|13:00 EDT
Boston Sci Nabs FDA Approval for Agent DCBMar 1, 2024|2 Min Read
Masimo Takes Apple's Hail Mary Pass in StrideFeb 29, 2024|3 Min Read